The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for C Johansson


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.EBI
The Institute of Cancer Research
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor.EBI
Icahn School Of Medicine At Mount Sinai
Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction.EBI
Astrazeneca
Discovery by Virtual Screening of an Inhibitor of CDK5-Mediated PPARγ Phosphorylation.EBI
Astrazeneca
First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53.EBI
University of Oxford
Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition.EBI
Institute of Biomolecular Chemistry (Icb)
Discovery of a Potent and Selective Fragment-like Inhibitor of Methyllysine Reader Protein Spindlin 1 (SPIN1).EBI
Icahn School Of Medicine At Mount Sinai
A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function.EBI
University of Oxford
Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity.EBI
National Center For Advancing Translational Sciences
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitorsBDB
Merck Sharp & Dohme